Overview
Proparacaine is a topical anesthetic drug of the amino ester group. It is found in ophthalmic solutions at a concentration of 0.5% as the hydrochloride salt.
Background
Proparacaine is a topical anesthetic drug of the amino ester group. It is found in ophthalmic solutions at a concentration of 0.5% as the hydrochloride salt.
Indication
Used as a local (ophthalmic) anesthetic.
Associated Conditions
- Chronic Lymphocytic Leukemia (CLL) - Refractory
- Follicular Lymphoma ( FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Multiple Myeloma (MM)
- Myelodysplastic Syndrome
- Primary Amyloidosis
- Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Research Report
Proparacaine: A Comprehensive Pharmacological and Clinical Review
I. Introduction to Proparacaine
A. Overview and Significance
Proparacaine is a topical anesthetic agent extensively employed in ophthalmic practice. Its primary utility lies in its capacity to induce rapid-onset, short-duration anesthesia of the corneal surface, thereby facilitating a wide array of diagnostic and minor surgical procedures that would otherwise be uncomfortable or impracticable.[1] The ability of Proparacaine to provide effective local anesthesia is crucial for ensuring patient comfort and cooperation during these interventions. This report aims to provide a comprehensive examination of Proparacaine, referencing its DrugBank ID DB00807 and CAS Number 499-67-2, and its classification as a Small Molecule topical anesthetic.[1] The widespread application of Proparacaine highlights a significant clinical requirement for reliable and fast-acting topical anesthesia in ophthalmology. Its effectiveness is, however, counterbalanced by specific safety considerations, particularly regarding corneal health, which necessitate informed and cautious clinical application.
B. Chemical Nature and Formulation
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2008/07/17 | Phase 2 | Completed | |||
2008/06/25 | Early Phase 1 | Terminated | |||
2008/06/18 | Phase 1 | Terminated | |||
2008/06/17 | Phase 1 | Completed | |||
2008/06/12 | Phase 2 | Completed | |||
2008/06/05 | Phase 2 | Completed | Cristina Gasparetto | ||
2008/06/04 | Phase 3 | Completed | |||
2008/06/02 | Phase 1 | Terminated | |||
2008/05/26 | Phase 2 | Terminated | |||
2008/05/16 | Phase 2 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |